Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD328 Mouse anti-Human, PE, Clone: F023-420, BD

Mouse Monoclonal Antibody

Supplier:  BD Biosciences 558372

Catalog No. BDB558372


Only null left
Add to Cart

Description

Description

The F023-420 monoclonal antibody specifically recognizes CD328 which is also known as sialic acid binding Ig like lectin 7 (Siglec-7). CD238 is an I-type lectin of approximately 65 kDa, expressed as a monomer on a major subset of NK cells and a subset of CD8+ cells. It is also expressed at moderate levels on monocytes and weakly on granulocytes. Siglecs (sialic acid/immunoglobulin/lectin) are a family of I-type lectins that bind to sialic acids on the cell surface. They are a family of carbohydrate binding proteins within the immunoglobulin superfamily. Siglecs are integral membrane proteins with extracellular N-terminal, V-set Ig domains, followed by variable numbers of C2-set Ig domains.

TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD328
Monoclonal
PE
Aqueous buffered solution containing BSA, protein stabilizer, and ≤0.09% sodium azide.
Recombinant Siglec-7
100 Tests
Immunology
Human
IgG1 κ
Flow Cytometry
F023-420
Siglec-7
Mouse
Affinity Purified
RUO
Primary
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.